Consensus Tenet Healthcare Corporation

Equities

THC

US88033G4073

Real-time Estimate Cboe BZX Other stock markets 10:43:04 2024-05-03 am EDT			5-day change	1st Jan Change
119.4 ^USD	+0.38%		+24.29%	+58.11%

May. 01	UBS Adjusts Tenet Healthcare Price Target to $150 From $137, Maintains Buy Rating	MT
May. 01	RBC Raises Tenet Healthcare Price Target to $136 From $109, Maintains Outperform Rating	MT

Evolution of the average Target Price on Tenet Healthcare Corporation

Price target over the last 5 years

History of analyst recommendation changes

1f56cd3b3249c446b3.saqeaZNqz-cjTXh1ykVigAkBH6ftnoAzHu1SkRQ1R-c._M7ML6tH_r1BKiAH_A0psHxtbsiF9-8Cct8R3VNMD9fa-88i_A2anlMETA~2eb0dce17caa76856fcdf2ae446ccff2

Analyst Recommendations on Tenet Healthcare Corporation

UBS Adjusts Tenet Healthcare Price Target to $150 From $137, Maintains Buy Rating	May. 01	MT
RBC Raises Tenet Healthcare Price Target to $136 From $109, Maintains Outperform Rating	May. 01	MT
Deutsche Bank Raises Tenet Healthcare Price Target to $126 From $100, Maintains Buy Rating	Apr. 12	MT
Wolfe Research Upgrades Tenet Healthcare to Outperform From Peer Perform, Price Target is $122	Mar. 27	MT
Mizuho Adjusts Tenet Healthcare's Price Target to $110 From $100, Keeps Buy Rating	Mar. 11	MT
UBS Adjusts Tenet Healthcare Price Target to $137 From $94, Maintains Buy Rating	Feb. 09	MT
Mizuho Raises Price Target on Tenet Healthcare to $100 From $90, Keeps Buy Rating	Feb. 09	MT
Cantor Fitzgerald Adjusts Price Target on Tenet Healthcare to $104 From $94, Maintains Overweight Rating	Feb. 09	MT
Deutsche Bank Adjusts Tenet Healthcare Price Target to $100 From $75, Maintains Buy Rating	Feb. 09	MT
RBC Adjusts Price Target on Tenet Healthcare to $109 From $97, Keeps Outperform Rating	Feb. 09	MT
RBC Raises Price Target on Tenet Healthcare to $97 From $72, Keeps Outperform Rating	Jan. 24	MT
JPMorgan Adjusts Tenet Healthcare's Price Target to $81 From $91, Maintains Overweight Rating	Nov. 17	MT
Goldman Sachs Cuts Tenet Healthcare's Price Target to $85 From $98, Keeps Buy Rating	Nov. 09	MT
UBS Cuts Tenet Healthcare Price Target to $94 From $104, Maintains Buy Rating	Nov. 01	MT
Raymond James Adjusts Price Target on Tenet Healthcare to $90 From $95, Maintains Strong Buy Rating	Nov. 01	MT
Mizuho Adjusts Tenet Healthcare's Price Target to $77 From $94, Maintains Buy Rating	23-10-31	MT
Deutsche Bank Adjusts Tenet Healthcare Price Target to $75 From $86, Maintains Buy Rating	23-10-31	MT
RBC Cuts Price Target on Tenet Healthcare to $72 From $87, Keeps Outperform Rating	23-10-31	MT
North American Morning Briefing : Rate Decisions, -2-	23-10-30	DJ
Wells Fargo Adjusts Price Target on Tenet Healthcare to $71 From $83, Maintains Overweight Rating	23-10-20	MT
Cantor Fitzgerald Raises Price Target on Tenet Healthcare to $94 From $76, Maintains Overweight Rating	23-09-14	MT
Goldman Sachs Raises Price Target on Tenet Healthcare to $98 From $89, Maintains Buy Rating	23-08-14	MT
Credit Suisse Adjusts Tenet Healthcare's Price Target to $98 From $92, Keeps Outperform Rating	23-08-02	MT
Raymond James Adjusts Price Target on Tenet Healthcare to $95 From $85, Maintains Strong Buy Rating	23-08-02	MT
Deutsche Bank Adjusts Tenet Healthcare Price Target to $86 From $81, Maintains Buy Rating	23-08-01	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

118.9 USD

Average target price

126.7 USD

Spread / Average Target

+6.50%

High Price Target

165 USD

Spread / Highest target

+38.73%

Low Price Target

85 USD

Spread / Lowest Target

-28.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Tenet Healthcare Corporation

UBS
RBC Capital Markets
Deutsche Bank Securities
Wolfe Research
Mizuho Securities
Cantor Fitzgerald
JPMorgan Chase
Goldman Sachs
Raymond James
Wells Fargo Securities
Credit Suisse
Stephens Inc.
Citigroup
Truist Securities
Barclays
Jefferies & Co.
Loop Capital
SVB Securities LLC
Stifel Nicolaus
SVB Leerink
Seaport Global Securities
BofA Securities

Ratings for Tenet Healthcare Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar